APhA Election

The APhA Election includes elections for the APhA Board of Trustees—President-elect and two Trustees—and for the leadership of APhA–APPM and APhA–APRS. The APhA Honorary President is also determined during this election. The results of the election for the Board of Trustees and for the leadership of APhA–APPM and APhA–APRS are certified by the Committee of Canvassers, which is appointed by the APhA President.

All candidate information can be found in the 2021 APhA Voter's Guide. Additional recorded statements from each candidate are available on this webpage for voter reference.

Candidate open forum sessions are being scheduled throughout the voting period from March 15 to May 3. Recordings of candidate open forums will be compiled on this website following the sessions. If you have questions you would like to pose to candidates, please email them to, and the APhA Engage platform will be used to facilitate responses from all candidates. If you have any questions on the 2021 Election Cycle, please contact

Download the 2021 Voter's Guide

Vote Now

APhA Elections are open March 15, 2021–May 3, 2021. Ballots are now available. Cast your vote today.

Vote Now

2021 Election Timeline

October 5, 2020 — Application deadline for the 2021 APhA Election cycle
November/December 2020 — Committee on Nominations meets; election slate announced
March 12–15, 2021 — Slated candidates attend APhA2021 in Los Angeles, CA
March 15 – May 3, 2021 — Voting period for 2021 APhA Election
May–June 2021 — APhA Election results announced
March 18–21, 2022 — Successfully elected candidates installed at APhA2022 in San Antonio, TX

APhA Board of Trustees Candidates

APhA President-elect (2022–2023)
Valerie Prince, PharmD, FAPhA, BCPS

Valerie Prince, PharmD, FAPhA, BCPS, is grateful to be part of an interdisciplinary team taking care of patients at St. Vincent’s Family Medicine Residency Program. Her practice focuses on patient safety, substance abuse, transitions of care, and mentorship of student and resident pharmacists and physicians. Mercer University and an American Society of Health-System Pharmacy (ASHP)-accredited residency at Regional Medical Center at Memphis prepared her well. She has enjoyed practicing in acute care, ambulatory, independent, chain, and long-term care pharmacies. Her national-level involvement in APhA includes two terms on the Board of Trustees, APhA–APPM President, Speaker of the House of Delegates, and APhA Academy of Student Pharmacists (APhA–ASP) national officer. She is the immediate former Chair of the APhA House of Delegates Rules Review Committee. She received the Alabama Pharmacy Association Distinguished Service Award for her extensive state level involvement that included service as APA Research and Education Foundation (APAREF) President and APA Board of Trustees. She is a past national president of Phi Lambda Sigma leadership society and was recognized as National Chapter Advisor of the Year while at Samford University. She served the Alabama Board of Pharmacy for several years on the Committee on Rehabilitating Impaired Pharmacists. She is a recipient of the Linwood F. Tice Friend of APhA–ASP Award and the APhA–APPM Distinguished Achievement in Clinical Practice Award. She is an APhA Fellow. She has a long record of community service and mentoring and is currently serving on the Governor’s Task Force on Opioids.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

I have strengths in “selling” the value of a pharmacist, establishing relationships, and in team- based care. I have established clinical pharmacy services where I wasn’t invited, not particularly welcomed, and was required to cost-justify my position. Each time I persisted and created demand for my services from other disciplines. The fight for recognition and financial viability I experienced on a personal level is of much greater importance on a global level as provider status. I have successfully navigated roles in accreditation processes in both hospitals and academic environments. In my current practice I have unique opportunities to engage medical residents including serving as the only non-physician in a physician mentoring program. I have a long history of involvement in the field of substance use disorders, a major public health and safety issue. I was blessed by 18 years of the best leadership training in pharmacy through APhA leadership positions. One of the strengths for which I am most grateful is the ability to recruit and encourage new leadership in APhA. I’ve had the honor to mentor many former APhA presidents, BOT members and student pharmacists. I have accomplished major initiatives such as revision of the APhA policy process through gaining “buy in” from other leaders and members and laying the groundwork for restructuring APPM. I served a leadership role in organizing and facilitating the initial Federal pharmacists’ caucuses as well as serving as an advocate for our members who are part of the recovering (from substance use disorders) community. I can cast a vision, influence others to believe in the vision and in themselves, and lead others to work toward the vision. I am a strong and servant leader. I humbly ask for your vote for a chance to give back to the profession and APhA family I love.

Wendy Weber, PharmD, MBA, FAPhA, BCPS

Wendy Weber, PharmD, MBA, FAPhA, BCPS,  is a proud graduate of North Dakota State University. She obtained her MBA from the University of Nebraska at Omaha. Dr. Weber is currently a Senior Associate at Rainmakers Strategic Solutions, a government and commercial contractor, serving as the Lead Pharmacist for the Medicare Part D formulary review contract. She also fills in at Boystown National Research Hospital as needed. As a pharmacist for over 20 years, she has spent the majority of her career in clinical and administrative positions within academic medical centers, specifically pediatrics, neonatology, critical care and emergency medicine. She has also practiced in community pharmacy, home infusion and administrative consulting. Dr. Weber is a lifelong APhA member who is currently serving as a Trustee on the APhA Board of Trustees. Her past leadership experiences with APhA includes APhA–APPM President and Trustee, APhA Foundation Director, and APhA–ASP National Member-at-large. Dr. Weber has served as a delegate to the APhA House of Delegates for 20 years and in many other appointed and elected leadership positions within APhA–APPM and was the inaugural chair of the New Practitioner Editorial Advisory Board. She is a member of the Nebraska Pharmacists Association where she has served on various committees and spends a lot of time volunteering at her church.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

As a current Trustee, I know where we are going. APhA has new leadership with vision and a large social media following. Social media influences change and we need change! Now is the time to engage the public. We need to bring awareness to the deceptive payment practices to make payment reform a reality. We need to challenge employers to adopt the recommendations from the 2019 Consensus Conference on well-being. We need to continue to develop resources for practice change so we are ready when recognized as providers. I understand what we need to do to serve members, grow membership and ensure the sustainability of APhA. I will continue to work with my fellow Trustees to get it done. Anyone who knows me will tell you, I am not afraid to ask difficult questions. I like to challenge the status quo. The President needs to ensure the Board is focused on our mission and vision when making decisions and taking time to critically evaluate what we want to do and why. A highly functioning Board needs to have open discussions that respect all opinions. Everyone’s opinions and insights are valued. I am a leader who can relate to you. I am a practicing pharmacist. I have been unemployed and underemployed. I understand life with job uncertainty. As an Association leader I always encourage others to run for office or get involved with the SIGs or a committee, especially those who provide a unique perspective. APhA is a diverse organization with a diverse group of volunteer leaders who make us stronger and help us identify gaps in member experiences. As an APhA Presidential Officer, I know that I will have a lot to learn, but I also know I have a lot to offer as a pharmacist, entrepreneur, woman, and mother.

APhA Board of Trustees (2022–2025), Pair I
Vibhuti Arya, PharmD, MPH

Vibhuti Arya, PharmD, MPH,  is a Professor at St. John's University College of Pharmacy and Health Sciences and Clinical Advisor to the New York City Health Department of Health and Mental Hygiene (NYC DOHMH). In her role, she works to integrate pharmacists into public health initiatives, particularly among high-risk, medically underserved areas in NYC, and advises on legislation. To date, Dr. Arya has been engaged with several efforts including public health detailing, policy planning, expanding naloxone access through community pharmacies, syndromic surveillance, correctional health services, and emergency preparedness. She also serves on the Health Department’s Institutional Review Board. Dr. Arya has demonstrated exemplary leadership across professional bodies and non-profits throughout her career. Within APhA, she is a former APhA-ASP National President and New Practitioner leader, helps lead the APhA-APPM Public Health SIG, and serves on the APhA Taskforce on Systemic Racism. Dr. Arya is also a Global Lead for Equity Workforce Development for the International Pharmaceutical Federation (FIP). Most recently, she received the Sustained Contributor Award from the American Public Health Association Pharmacy Section, and led a team to win the MIT Hacking Racism Challenge in Social Justice & Policy. Dr. Arya engages students and colleagues to examine programs and policies through the lens of equity, applying social justice principles to reduce inequities in care. She recently gave a TEDx talk on structural racism. Dr. Arya completed the Pharmaceutical Care Leadership Residency at the University of Minnesota, and MPH from the Johns Hopkins Bloomberg School of Public Health.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

Advocacy, Community, and Equity are central to my experience in understanding and advancing pharmacists’ role in improving community health. Throughout my career, I have worked to intentionally bridge the gap between pharmacy and public health, with a focus on mentoring students and new practitioners to see themselves as key contributors and future leaders in advancing pharmacists’ role in public health. I have increased the visibility of pharmacists as partners in public health, serving as the subject matter expert to the Deputy General Counsel at the NYC Health Department, and forming advisory groups that put pharmacists at the decision-making table. Focusing on meaningful community engagement and grassroots advocacy, I have developed innovative projects, bringing together technology, public health, pharmacists, and local community partners. One such project included mapping NYC pharmacies with social determinants of health, and provided data driven insights that continue to guide strategic priorities, helped close the equity gap among high-poverty neighborhoods, and brought access to medications for patients who were displaced by Hurricane Maria. Equity continues to be the common thread that weaves throughout my career. As an experienced facilitator of racial justice work, I create tools and resources that integrate equity into strategic planning, project management, and education; I am now bringing this work to the international sphere as Global Lead for Equity Workforce Development for the International Pharmaceutical Federation (FIP). I will bring this lens to the APhA Board of Trustees and further the conversation on equity, both for patient care and our profession. By increasing advocacy efforts for improved patient care demonstrating pharmacists as key community partners, mentoring students and new practitioners to lead our profession, and holding equity as a priority, APhA will be better positioned to serve our members, our future leaders, our profession, and ultimately our patients.

Sean Jeffery, PharmD, BCGP, FASCP, AGSF

Sean Jeffery, PharmD, BCGP, FASCP, AGSF, is Director of Clinical Pharmacy Services at Integrated Care Partners, an accountable care organization responsible for Hartford HealthCare’s value-based practice transformation. He leveraged his training in geriatrics and time as a consultant pharmacist within the VA system into leading pharmacy population health efforts within this ACO. Dr. Jeffery works with providers and payers to create novel pharmacist services. He is a tireless advocate for recognition of pharmacists as health care providers. Dr. Jeffery is responsible for the ACO's pharmacy network development, performance and strategy. Dr. Jeffery is also a Clinical Professor at the University of Connecticut School of Pharmacy. Dr. Jeffery earned his bachelor of science from the University of Connecticut and his PharmD from The Ohio State University and completed a specialty residency in geriatrics at the Durham VA and Duke Center for Aging. While at VA Connecticut, Jeffery started a PGY2 Geriatrics Residency. In addition to APhA, Jeffery co-chairs the State of CT's HIE Medication Reconciliation Committee, served as President and Chairman of the Board of Directors for ASCP from 2012–2014 and chaired the AACP’s Geriatrics SIG in 2007–2008. He also chaired the Polypharmacy Special Interest Group for the American Geriatrics Society (AGS). He was recognized as a Fellow of the AGS and an Ohio State University Distinguished Alumni and received the Elan Biopharmaceuticals Innovative Pharmacy Practice Award. Jeffery is completing his first term as an APhA Trustee. He is inspired by APhA members and would be honored to be re-elected.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

I’m excited to be a pharmacist practicing at this pivotal moment in our profession! The pandemic has opened opportunities for us to rethink how healthcare is delivered. Pharmacists will show the nation our incredible capacity to vaccinate every community from this virus. Like many others during the pandemic, I've found myself helping out in new and unexpected ways, such as entering COVID orders in our clinical command center. Being able to adapt to circumstances and embrace change is a skill I've worked hard to develop. I'm also very fortunate to have served in various leadership roles in APhA, ASCP, AGS and AACP. Additionally, I am co-chair of a multi-stakeholder group of technologists, informaticians, providers, pharmacists and patient advocates on a medication reconciliation committee in Connecticut. Each of these experiences has helped me be a more effective leader. Working with colleagues with different backgrounds has given me a unique perspective that I bring to APhA. In serving as president of the ASCP, I gained invaluable experience in how organizations work, collaborate, and expand members resources & how pharmacy associations can advance our profession, especially when working together. Now more than ever, our profession needs a unified voice, clarity of purpose, and strong leadership. APhA must continue to cultivate inclusivity and speak on behalf of all pharmacists in advocating for the future of pharmacy practice. My years of committee service have prepared me to be an effective Trustee at APhA. One of my strengths is being a good listener. It helps ensure I hear diverse opinions. Eventually the pandemic will pass and in its wake will be new opportunities for pharmacists to deliver value based healthcare. I helped create APhA's current strategic plan and would be honored to help implement it over the next 3-years if reelected.

APhA Board of Trustees (2022–2025), Pair II
Stephen Carroll, PharmD, MBA

Stephen Carroll, PharmD, MBA, received his PharmD in 2005 from the University of Arkansas for Medical Sciences College of Pharmacy. He completed his MBA at the University of Arkansas at Little Rock in 2006. He also holds a bachelor’s degree in Biological Sciences from Arkansas State University. He currently practices and is a co-owner in AllCare Specialty Pharmacy in Little Rock, Arkansas. Prior to working in specialty pharmacy, Dr. Carroll was the Chief Operating Officer of W.P. Malone, Inc, a company that included retail, long term care, and correctional pharmacies. Dr. Carroll served on the Arkansas Pharmacists Association (APA) Board of Directors from 2010–2020 and served as President of the APA Board of Directors in 2018–2019. Dr. Carroll was appointed to the Arkansas Medical Marijuana Commission and served as a commissioner from 2016 to 2019. Dr. Carroll was awarded the Arkansas Pharmacists Association Young Pharmacist of the Year in 2014. Dr. Carroll has led several grassroots efforts to further the profession of pharmacy in his home state to protect pharmacists from the overreaching practices of PBMs. He has participated in the state legislative process to expand the scope of practice for pharmacists in Arkansas. Dr. Carroll is an active member of APhA and the National Association of Specialty Pharmacy.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

In my over 20 years of practice in pharmacy, I have seen many different areas of practice in pharmacy. I have worked in independent and chain retail pharmacy, long term care pharmacy, correctional pharmacy, and specialty pharmacy. I have worked with 340B entities and I understand the importance of the 340B program. I also learned a great deal about medical marijuana by serving as a Commissioner appointed to the Arkansas Medical Marijuana Commission. During my leadership in the Arkansas Pharmacists Association (APA), I promoted the principle that the Arkansas Pharmacists Association represents all pharmacists regardless of practice setting. I believe that it takes pharmacists from all practice settings, through grassroots efforts, to bring about changes that we all want and need in pharmacy. My experiences in leadership positions have allowed me to demonstrate that pharmacists are necessary in direct patient care for new and emerging therapies. My practice settings have been beta sites for innovative pharmacy automation on several occasions. I have worked directly with technology companies to influence automation that best serves the practice of pharmacy and allows pharmacists to focus on patient care. During my leadership with the APA, I worked with state legislators to develop and pass legislation to protect the practice of pharmacy by requiring PBM licensure. As a result of a meeting I attended as APA President with the Governor of Arkansas, reimbursement for flu shot administration by Arkansas pharmacists was changed from $0 to a reasonable rate. Finally, I have worked with all 50 State Boards of Pharmacy to obtain pharmacy licensure and I am licensed as a pharmacist in 16 states. These experiences give me confidence that I can serve the membership of the American Pharmacists Association on the APhA Board of Trustees. I ask for your vote for the Board of Trustees.

Scott Tomerlin, PharmD, CPh

Scott Tomerlin, PharmD, CPh, is a Florida licensed pharmacist. He is the Pharmacy Manager for Walgreens Pharmacy in Rockledge, FL. Born and raised in Louisville, KY, Scott is a 2006 graduate of the Mercer University College of Pharmacy in Atlanta. It is there that he met his future wife, Teresa, during their first semester of pharmacy school. Teresa is a pharmacist for CVS Pharmacy inside Target. He and his wife have three children: John, Nathan and Isabella. Scott has had training in the independent and chain community, hospital, ambulatory and nuclear settings. He also had the opportunity to complete a 5-week international rotation in Hiroshima, Japan, at the University of Hiroshima during his fourth year of rotations. Scott has served in numerous leadership roles within the profession of pharmacy, including President and Chairman of the Board of the Florida Pharmacy Association, President of the Brevard County Pharmacy Association and, most recently, on the APhA Political Action Committee Board of Governors. Scott is the recipient of the Distinguished Young Pharmacist of the Year Award by the Florida Pharmacy Association in 2007 and the Mercer University College of Pharmacy Young Alumni of the Year award in 2016. He most recently served on the Mercer University College of Pharmacy Alumni Association Board. Scott is an Eagle Scout and proudly gives back to the community through his involvement in the American Cancer Society, as well as serving as Treasurer of his son’s Boy Scout troop.

What unique attributes and skills would you bring to the APhA Board to support the advancement of the Association's priorities?

As Chairman of the Board of Directors for the Florida Pharmacy Association (FPA) in 2017 and President in 2016, I have had extensive experience in multilateral team building across a state as large as Florida with many different backgrounds of pharmacy practice, which has enabled me to see the practice and advancement of pharmacy from many unique perspectives. I also served on the Florida Society of Health-Systems Pharmacists Board of Directors, working alongside clinical hospital pharmacy practitioners across the state and country. In my leadership role at FPA, I was proud of how the membership grew under my tenure and this was, in part, due to strategic decisions and financial and operational directives advanced by my leadership team. While FPA President, we were able to successfully advocate and help advance legislation that dealt with reversing restricted network closures, which had a positive impact on many of our independent community pharmacy owners in Florida, helping them survive a very challenging business climate. I believe we must continue to advocate for our profession, and I have done this both in word and action. I have had experience in pharmacy advocacy with numerous visits to the U.S. Capitol alongside a diverse group of pharmacists and student pharmacists and additionally, I serve on the American Pharmacists Association PAC Board of Governors and the Florida Pharmacists Political Action Committee. As an employee pharmacist, I can bring to the APhA Board a unique and fresh perspective, representing other employee pharmacists and technicians from across our country, their ambitions, and their concerns. I am excited to serve, and it would be an honor to have the opportunity to continue to give back to our beloved profession by serving on the APhA Board of Trustees.

APhA Honorary President (2022–2023)
Mary L. Euler, PharmD, FAPhA

Mary L. Euler, PharmD, FAPhA, serves as Professor and Associate Dean for Admissions and Student Affairs at the West Virginia University School of Pharmacy. Prior to arriving in Morgantown, WV, she served for 4 years as McGee Chair for Doctoral Studies and Associate Dean for Academic Affairs at the University of Charleston School of Pharmacy and 21 years as a faculty member and administrator at the University of Missouri–Kansas City School of Pharmacy. Her academic career includes experience in curricular design, faculty development, distance education, experiential learning, leadership development, and academic service learning. Her teaching interests include professional communications, pharmacy history, patient education, health care ethics, leadership development, self-awareness training, and vaccine-preventable illnesses. She is an APhA certified immunizing pharmacist and trainer. Dr. Euler is also the Associate Executive Director for Phi Lambda Sigma, the pharmacy leadership society, after having served as the Executive Director from 1999–2020. She is also the recipient of many professional and community service awards, including the APhA–ASP Outstanding Advisor Award, the APhA Gloria Niemeyer Francke Leadership Mentor Award, the Missouri Pharmacist Making a Difference Award, and the University of Missouri–Kansas City’s Mathew Wilson Award. In 2011, she was inducted as an APhA Fellow. Engaged in her community, Dr. Euler co-chaired the H1N1 education committee for the Kanawha County Health Department and served on the health department’s Multi-Agency Emergency Response Task Force. She is a certified trainer–facilitator for GIANT Worldwide leadership development programs.

APhA–APRS Candidates

APhA–APRS Basic Sciences Section Chair-elect (2022–2023)
Abir El-Alfy, PhD

Abir El-Alfy, PhD,  is an Associate Professor of Biopharmaceutical Sciences–Pharmacology at the Medical College of Wisconsin School of Pharmacy (MCWSOP). She is a graduate of the Faculty of Pharmacy, Cairo University, Egypt. She has an MS in Microbiology and a PhD in Pharmacology and Toxicology from the University of Mississippi. Before joining MCWSOP, Dr. El-Alfy held several faculty positions in pharmacy and medical schools. Dr. El-Alfy held several leadership positions, including Director of the Behavioral Neuroscience Core-NPN at the School of Pharmacy, University of Mississippi, chair of several governance committees at different pharmacy schools, and spearheaded the development and implementation of the MCW SOP co-curriculum program. Dr. El-Alfy’s teaching experiences include physiology, biochemistry, pharmacology, and toxicology courses at both the undergraduate and graduate levels. She is a seven-time recipient of teacher of the year award in the College of Pharmacy. She also received the 2015 Chicago State University Faculty Excellence Teaching Award and the 2020 MCW Faculty Service Award. Dr. El-Alfy is an active member of many professional societies and acts as a grant, dissertation, and manuscript reviewer for various national and international organizations. Dr. El-Alfy's research interests focus on the role of the endocannabinoid system in neuropsychiatric disorders. The ultimate goal of this research is to develop new therapeutic targets for the treatment of neuropsychiatric disorders. Dr. El-Alfy has more than 40 peer-reviewed publications and 100 national and international presentations. She is a co-inventor of two provisional patents and one full patent. She has received several research grant awards.

Statement of Candidacy

1) Establishing collaborative research: Establish an initiative that focuses on research projects that investigate health-related issues from a translational approach, with clear collaboration between pharmaceutical and clinical researchers. The initiative can also help pharmaceutical researchers connect with clinical ones to help initiate their translational research programs across institutions. Relevant Experience: During my tenure at Chicago State University, I collaborated with clinical pharmacy, psychology, and social science faculty to acquire an R24 grant that investigated the role of mindfulness in helping patients with substance use disorders (SUD). At MCW, I’m currently collaborating with medical school faculty to examine the use of chick embryos as a model to examine the cardiac effects of various opioids. In addition to basic research, I collaborate with clinical faculty to develop and implement various interprofessional educational (IPE) experiences for our student pharmacists. 2) Establishing a mentoring program: With the changing face of pharmacy, junior faculty trained in pharmaceutical sciences sometimes struggle to transition to the new roles in academic pharmacy. Pairing these junior faculty with experienced mentors can guide them through the demands of their new roles. Relevant Experience: I currently mentor several faculty in our program, as well as serve as a mentor for the AACP Biological Sciences SIG. 3) Establishing an initiative for community engagement: Emphasizing the role of basic, clinical, social, economic, and administrative science members in identifying health issues and ways to address and educate the public. Relevant Experience: As the faculty lead for a co-curriculum program, I oversee various community engagement activities that our students participate in. I give presentations on various health issues and my research efforts to address them. Recently, I have focused on disseminating knowledge regarding cannabis-based products and educating the public with available evidence for therapeutic application, adverse effects, interactions, and precautions.

Heidi Mansour, PhD, RPh

Heidi Mansour, PhD, RPh, is a tenured Associate Professor in the College of Pharmacy and College of Medicine at The University of Arizona (The UA) in Tucson, AZ. Dr. Mansour’s leadership positions include Director of the Pharmaceutics/Pharmacokinetics Track and Director of the PharmD/PhD dual-degree program. Dr. Mansour is a Registered Pharmacist and has practiced in community pharmacies, a clinic pharmacy, and an urgent care/acute care pharmacy. In addition, she worked as a Clinical Pharmacy Specialist managing drug formularies and a Clinical Instructor. She is active in leadership committee positions in the American Thoracic Society (ATS), ISAM (International Society of Aerosols in Medicine), American Association of Colleges of Pharmacy (AACP), and at The UA. Dr. Mansour has been an active member of APhA–APRS for many years. Working on committees, she has been active in creating a new faculty teaching toolkit, pharmacy professional committee, professional advisory council, curriculum committee and sub-committees, and AACP Pharmacy Virtual Fairs and Discovery Pharmacy Open Houses. Dr. Mansour has published 92 peer-reviewed scientific journal papers, 13 book chapters, two edited books, and over 100 scientific conference abstracts. In addition, Dr. Mansour is an active inventor with nine patents and two licenses on inventions from her innovative research program. She is co-founder of a start-up spin-off company, Surastar Pharmaceuticals. Dr. Mansour serves on the editorial advisory boards of the journals Royal Society of Chemistry Molecular Systems Design & Engineering, APhA/FIP Journal of Pharmaceutical Sciences, Pharmaceutical Technology, and Pharmaceutics.

Statement of Candidacy

The top three priorities of the Academy should be: 1) Research and Scholarship; 2) Career Development, Mentoring, and Leadership Development; and 3) Diversity and Inclusivity Promotion. I have extensive experience and expertise in research/scholarship, career development/mentoring/leadership development, and diversity/inclusivity promotion. 1) I have a demonstrated track record in research and scholarship. I lead an active multidisciplinary research program comprising a Research Assistant Professor, Postdoctoral Scholars, PharmD student researchers, and graduate students. My research program has produced a number of Assistant Professors who have been awarded tenure at major research universities in the United States and in the Republic of South Korea. I created new courses for our pharmaceutics graduate program, our PharmD professional program, and our undergraduate program. I am committed to excellence in research and scholarship and promoting such opportunities. 2) I have a demonstrated track record in career development, mentoring, and leadership development. As Major Professor, I have successfully graduated three PhDs. As Major Advisor, I have successfully trained over 10 Postdoctoral Scholars/Fellows and many PharmD student researchers who have published with me. I serve as a faculty mentor to several early-stage faculty members. I am committed to mentoring trainees at all stages and early-stage junior faculty members. I am committed to providing more opportunities for professional development and leadership training at various stages. 3) I have a demonstrated track record in promoting diversity and inclusivity, starting with my own research program, which consists of minorities, and my active mentoring of minorities in various minority health disparity programs funded by the National Institutes of Health and National Science Foundation. All of my PhD graduates as Major Professor are minorities. Several of my PharmD student researchers and undergraduate researchers who have published with me are minorities. I am committed to promoting diversity/inclusivity and enhancing career development of minorities.

APhA–APRS Clinical Sciences Section Chair-elect (2022–2023)
Jackoline M. Costantino, PharmD, BCCP

Jackoline M. Costantino, PharmD, BCCP,  is the Clinical Coordinator at Brooke Army Medical Center (BAMC) in San Antonio, TX. Dr. Costantino received her PharmD from Idaho State University College of Pharmacy in 2013. She then completed a PGY1 pharmacy residency at the University of Maryland Medical Center and a PGY2 cardiology residency at Advent Health Hospital in Orlando, FL. Dr. Costantino is passionate about training and mentoring pharmacy students and residents. She currently serves as a preceptor within BAMC's PGY1 pharmacy residency, ensuring military pharmacists and technicians are equipped with the knowledge, skills, and abilities to provide high-quality pharmaceutical care wherever their mission takes them. Having practiced as a pharmacist in a variety of settings and a number of states, she is keenly aware of many of the opportunities and challenges we face as a profession and is dedicated to demonstrating the value of pharmacy.

Statement of Candidacy

My experience in both community and health-system pharmacy have provided insights into the value pharmacists can provide at various points on the health care continuum. Several priority areas for the Academy should be to increase awareness of APhA as the professional home for pharmacists, expand opportunities to recognize the valuable contributions made by pharmacists and pharmacy technicians, and leverage the collective knowledge of both APPM and APRS to increase the body of knowledge that demonstrates the value of pharmacy to key stakeholders. I feel that my current role within federal pharmacy and my unique journey in the profession, having moved from community pharmacy to community health-system, back to residency, to an academic medical center, and to academia, will bring a unique perspective and highlights the constantly evolving nature of pharmacy that many pharmacists are having to navigate today.

APhA–APRS Economic, Social, and Administrative Sciences Section Chair-elect (2022–2023)
Abir Kahaleh, PhD, MS, BPharm, MPH

Abir Kahaleh, PhD, MS, BPharm, MPH,  has devoted her academic career to pharmacy and public health education. She earned a Doctor of Philosophy (Pharmacy) from the Department of Social and Administrative Sciences at the College of Pharmacy at the University of Michigan in Ann Arbor. She obtained a Masters in Health Management and Policy from the School of Public Health at the University of Michigan. She obtained a Masters of Pharmaceutical Sciences from the Division of Pharmacy and Healthcare Administration at the University of Toledo after completing her BPharm. Dr. Kahaleh completed several certifications at APhA. She completed Advanced Motivational Interviewing, OTC Advisor Advancing Patient Self-Care, Pharmaceutical Care for Patients with Diabetes, Lipid Management Program, Pharmacist-Provided Immunization Program, and Delivering Medication Therapy Management in the Community. Dr. Kahaleh published books, book chapters, and peer-reviewed journal articles. She collaborated with her colleagues on publishing APhA books: The Pharmacist in Public Health: Education, Applications, and Opportunities and Pharmacy: An Introduction to the Profession. She also served on the Advisory Board for the Journal of the American Pharmacists Association (JAPhA). Dr. Kahaleh is serving as the Chair of the AACP Global “Pharmacy” Education Sig. She previously served as the Chair of the AACP Experiential Education Section and the Chair of the Curriculum Sig. In addition, Dr. Kahaleh is serving on the Editorial Advisory Board for the American Journal of Pharmacy Education (AJPE). Lastly, Dr. Kahaleh was invited by ACPE to participate in several accreditation site visits to various national and global colleges of pharmacy.

Statement of Candidacy

1) Advocate for provider status and payment reform for pharmacist-provided services. 2) Educate pharmacists, fellows, residents, and student pharmacists to provide quality care services to all patients. 3) Empower pharmacists as essential public health professionals.

Kevin Lu, PhD, FISPE, BPharm

Kevin Lu, PhD, FISPE, BPharm, is Associate Professor (with tenure) of Pharmacy Administration at the University of South Carolina College of Pharmacy. Lu currently sits on the Editorial Board of the Journal of the American Pharmacists Association (JAPhA), is a mentor for pharmacy residents for JAPhA, and a grant reviewer for APhA, NIH, and American Association of Colleges of Pharmacy (AACP). Lu is an elected Fellow of International Society of PharmacoEpidemiology (ISPE) and was Chair of Academic Council of ISPE, Chair of Drug Policy at American Public Health Association (APHA) and member of numerous committees of international conferences. He is also an Academic Editor for PLOS ONE and guest editor for Frontiers in Public Health, and a faculty councilor of the International Society of PharmacoEconomics and Outcomes Research (ISPOR). He has extensive experiences in mentoring junior faculty, PhD students and PharmD students. Most of his PhD students are faculty members at peer schools, and he worked closely with the pharmacy industry for collaborated research. He served as President of the Chinese Association of Columbia, and Vice Chair of the Board of Directors at East Point Academy, a charter school with more than 700 students. Lu earned his PhD in Pharmaceutical Health Services Research from the University of Maryland. His research interests include pharmacoepidemiology, pharmacoeconomics based on big real-world data. He maintains an active collaboration with colleagues in clinical practice for questions that matter to pharmacists. His research has resulted in numerous grants, publications, keynote speech, symposiums, podiums, and posters at national and international conferences.

Statement of Candidacy

I feel honored and humbled to have been selected as a candidate for APhA–APRS Economic, Social, and Administrative Sciences (ESAS) Chair-elect. I have spent all my professional career in pharmacy, working in support of a stronger role of pharmacy and pharmacists in the health care system. I have experiences in both academia as well as the pharmacy industry. Pharmacists’ essential roles in COVID-19 pandemic, the downward trend in pharmacy school enrollment, pharmacists’ professional development and related gender discrimination and racism, and patients’ access and affordability have all become significant challenges more than ever. The APhA–APRS ESAS section is well positioned to bring opinions, thoughts, and commitments and take on these challenges that economically, administratively, and socially impact pharmacists and pharmacy-related professionals. I am well positioned to serve as the Chair-elect during this time of challenges because of my deep understanding of not only challenges but also opportunities for us, as well as my rich leadership experiences in a variety of international/national conferences that have faced various aspects of these challenges and opportunities. I will connect the APhA–APRS ESAS Section with other organizations to promote awareness of pharmacists' role, as well as prioritize work consistent with the current APhA–APRS ESAS team. For instance, under my numerous years of leadership, the University of South Carolina College of Pharmacy became an organizational member at the 35th ISPE. My leadership experiences, strong networks with other pharmaceutical organizations, and my commitment to APhA will help me succeed in this position.

APhA–APPM Candidates

APhA–APPM President-elect (2022–2023)
Nicholas Dorich, PharmD

Nicholas Dorich, PharmD, is the Senior Manager, Pharmacy Accounts, at Pharmacy Quality Solutions Inc. (PQS), which operates the EQuIPP dashboard for pharmacies and health plans. He manages PQS relationships with pharmacy clients, as well as implementation and tracking of medication-related quality measure performance. Prior to PQS, Dr. Dorich led activities related to professional affairs, education, and research at the National Association of Chain Drug Stores (NACDS) and NACDS Foundation. This included projects related to pharmacist-led activities to improve public health outcomes related to immunization rates, expanded scope of practice for pharmacists, transitions of care, and responses to public health emergencies. Dr. Dorich earned his PharmD from the University of Rhode Island College of Pharmacy in 2011 and completed an Executive Residency with the National Association of Chan Drug Stores Foundation in 2012. Dr. Dorich is an active member with APhA, including service as APhA Academy of Pharmacy Practice & Management Executive Committee Member-at-large (2020–2022). In addition, Dr. Dorich has been active within the APhA House of Delegates, serving in a variety of Committee roles.

Statement of Candidacy

More than ever, patients need a health care system that is accessible, informative, and cost-efficient to maintain their health. Unfortunately, pharmacists are not widely accepted as an integrated member of the health care team, despite the education and training that makes them qualified for providing direct patient care services. In order to expand the role of the pharmacist and to improve the financial viability of pharmacy operations, the APhA Academy of Pharmacy Practice & Management should focus on several key initiatives: 1) Messaging: APhA has long advocated for pharmacist provider status and fair reimbursement of pharmacist services. Patients and employers are the ultimate consumer of health care, and the Academy should develop messaging for this audience. While advocacy efforts should continue with legislators and government officials, the strategy of the Academy should include direct messaging to the health care consumer. 2) Collaboration: The pharmacy profession should work with technology partners and patients to directly address how pharmacists should be utilized as a member of the health care team. Data tell a story! The story for expanded roles of the pharmacist begins with quantifying our impact through data that can be appropriately shared with a patient’s care team. 3) Education: In order to move the pharmacy profession forward, we need to change our practice. Effective use and expanded roles of pharmacy technicians will be essential to realize the pharmacist as a patient care provider. APhA–APPM must identify effective systems and training that position all pharmacy team members for smooth transitions into advanced pharmacy practice models. As your APhA–APPM President, I will work endlessly to see pharmacists recognized as a health care provider. My unique experiences with pharmacy education, public health, and health care data position me to bring a unique experience to the Academy and the APhA Board of Trustees.

Patricia Fabel, PharmD, BCPS

Patricia Fabel, PharmD, BCPS, is the Executive Director of the Kennedy Pharmacy Innovation Center and a Clinical Associate Professor at the University of South Carolina College of Pharmacy. She received her PharmD from the University of Rhode Island and completed a community pharmacy practice residency at the University of Georgia College of Pharmacy and Kroger Pharmacy. She has over 10 years’ experience developing and implementing patient care services in community pharmacy settings. Specifically, she has implemented medication therapy management (MTM), vaccination, health and wellness, adherence, and pharmacogenomics programs in both independent and chain pharmacies. In addition, Dr. Fabel has helped create and manage two statewide pharmacist coaching programs in partnership with South Carolina's Department of Health and Environmental Control. She has served as the Director for the college’s Community-based Residency Programs since 2015. Dr. Fabel is a former president of the South Carolina Pharmacy Association and is actively involved in APhA, serving as the Member-at-Large for the Academy of Pharmacy Practice and Management Executive Committee from 2019–2021. On a personal note, Dr. Fabel lives on 100 acres with her husband, Josh, daughter, Georgianna, and several animals (dogs, cats, goats, sheep and chickens).

Statement of Candidacy

The most pressing issue within the profession is the decreasing job satisfaction due to growing unemployment and poor working conditions caused by predatory business practices by PBMs and lack of national and state-level provider status. I believe the Academy could address this issue in three ways: 1) advocate for equitable reimbursement for services provided by pharmacists, which includes proactively exposing PBMs; 2) create opportunities for pharmacists to expand patient care services; and 3) educate members on how to perform and bill for these services. As a faculty member, I am able to network with pharmacists who are offering innovative services in various practice settings, as well as researchers and data scientists who can help demonstrate the value of pharmacists. As the residency program director, I oversee residency projects that involve implementing services. I have been responsible for implementing and growing sustainable patient care services in community pharmacies for the past 13 years. I am able to bring innovative ideas to the table and adapt them for use in a community practice, based on my own experience and those of our residents. As a former president of SCPhA and as Executive Director of the Kennedy Pharmacy Innovation Center, I have experience advocating for the profession to legislators, employer groups and third-party payers. I will use this experience to continue to advocate for equitable reimbursement and help expose PBMs at the regional and national level. Lastly, our members need access to education programs that provide explicit instructions and guidance, as well as opportunities to network. My extensive experience providing education programs to student pharmacists, technicians, and pharmacists will help me assist the Academy in developing their education agenda, member resources, and networking opportunities. I would welcome the chance to continue to serve APhA as the President-elect for the Academy.

APhA–APPM Executive Committee Member-at-large (2022–2024), Pair I
Chris Johnson, PharmD, MEd, BCACP

Chris Johnson, PharmD, MEd, BCACP, is an Assistant Professor of Pharmacy Practice at the University of Arkansas for Medical Sciences College of Pharmacy. His practice site is the UAMS Family Medical Center, where he provides chronic disease management under collaborative practice agreements for a variety of disease states and precepts student pharmacists, pharmacy residents, medical students, and medical residents. Dr. Johnson utilizes his rotations as an opportunity to prepare learners to work in interprofessional teams to provide high quality care to our most vulnerable patients. Additionally, Dr. Johnson serves a chapter advisor for the award-winning UAMS APhA–ASP chapter. Dr. Johnson graduated from Oregon State University and completed his PharmD at Concordia University Wisconsin School of Pharmacy. After graduation, he completed the 24-month Practice and Academic Leadership residency at Concordia. As part of the residency, Dr. Johnson developed pharmacy services at a Federally Qualified Health Center in the Milwaukee, WI, area. This residency program also provided him with the opportunity to complete a Master of Science in Education. Dr. Johnson has been involved in a number of service opportunities within APhA and the American Association of Colleges of Pharmacy since beginning his pharmacy career. He has been involved in multiple SIG and Academy committees within APhA, including the APhA–APPM Policy Standing Committee and co-chairing the CUP SIG Communications. Dr. Johnson previously chaired the AACP Junior Faculty Learning Community Committee and serves on the AACP Teacher's Seminar Planning Committee and AACP Bylaws and Policy Development Committee.

Statement of Candidacy

APhA is critical to advocating for solutions to a number of issues within the profession of pharmacy. Among these, fair and transparent reimbursement practices and provider status are crucial to the continued advancement of pharmacy practice and the improvement of patient care in the United States. Community pharmacists are struggling due to the unfair practices of PBMs, and this has caused a rash of pharmacy closures (>9500 closures between 2009–2015). Pharmacy closures make it more difficult for patients to access medications and initial health care. Additionally, there is a plethora of data that pharmacists improve health outcomes in a variety of disease states, but there are too few patients with access to these life-saving services. APhA is in a critical spot to advocate for pharmacists and patients on these issues. As APhA–APPM Member-at-large, I would work with APhA Executive Board and staff to provide resources and develop a program through which we can systematically involve our membership in advocating for legislative changes within our nation. Another issue that has been brought to the forefront of our profession by a number of courageous women is the impact of sexual harassment on our colleagues and trainees within the profession. Our profession is wonderfully diverse, bringing strength to pharmacy and better relationships with our patients. As APhA-APPM Member-at-large, I would work with these women to develop a shared reporting system, encompassing colleges of pharmacy, employers, and professional organizations, that would help victims report this behavior so that appropriate actions can be taken. Every member of our profession should be valued, encouraged, and mentored to pursue their passions without fear of sexual harassment. While we have work to do, I am proud to be a pharmacist and a member of APhA! Thank you for your consideration for APhA–APPM Member-at-large.

G. Blair Sarbacker, PharmD, BCACP, FAPhA

G. Blair Sarbacker, PharmD, BCACP, FAPhA, is currently working as an Associate Professor of Pharmacy Practice at Presbyterian College School of Pharmacy. She is practicing as a clinical pharmacist at Advanced Family Medicine, a rural primary care clinic, where she practices medication and disease state management. She received her PharmD from Wingate University School of Pharmacy in 2008. She completed an ASHP-accredited residency in Community Pharmacy Practice at the Community Healthcare Center by Kerr Drug in Lenoir, NC, in association with Wingate University School of Pharmacy. She obtained her Board Certification in Ambulatory Care, in addition to completing certificate training in the areas of immunizations and diabetes management. She is also certified to teach APhA’s Immunizations and Diabetes Certificate Programs. She has served as an advisor for APhA–ASP for 7 years.

Statement of Candidacy

I believe the top three priorities of the Academy of Pharmacy Practice & Management are: 1) To advance the role of the pharmacist: The role of the pharmacist is ever-changing as we adapt to the changes in the health care climate. As a profession, we need to come together to create new avenues to expand our services to increase job opportunities. As we continue to fight for provider status, we need to prepare ourselves to expand into new areas of practice (e.g., primary care, urgent care, rural health, etc.) so that when we achieve our goal of provider status, we are able to not only have a greater impact in patient care, but increase patient access to health care. 2) To advocate for the profession of pharmacy: APhA creates a strong voice for the profession of pharmacy. As an Academy, we need to support APhA’s efforts with grassroots advocacy. Understanding the issues surrounding pharmacy practice in all areas is important to help provide a collaborative voice as an Academy. 3) To support pharmacist growth through education: As our professional role continues to develop and new drug therapies become available to patients, continuing education is vital for professional growth. The Academy should continue to support clinical education, certificate training offerings, and leadership education. To stay well-rounded, educational offerings should occur at all levels, from novice to expert, and include topics on advocacy, ranging from where to begin to current issues in pharmacy. I absolutely love my profession and want to be a part of the change process. The Academy’s dedication to assisting members in enhancing the profession of pharmacy, improving medication use, and advancing patient care closely align with my professional priorities. I look forward to the opportunity to continue my service within APhA on the Academy level.

APhA–APPM Executive Committee Member-at-large (2022–2024), Pair II
Lalymar Havern, PharmD, MS, BCACP

Lalymar Havern, PharmD, MS, BCACP, is a community-based pharmacist passionate about the profession and providing better patient-centered care across the community pharmacy setting by empowering her fellow pharmacists. As a third-generation pharmacist, Dr. Havern is active in her father's independent pharmacy, which has been open for 55 years in San Juan, Puerto Rico. For the past 15 years, Dr. Havern has worked for Walgreens in a variety of roles, from traditional community to specialty in both community and corporate settings across the country due to her husband's active-duty status. Currently, she works in the Office of Clinical Integrity, where she is responsible for providing evidence-based clinical reviews to ensure the clinical integrity and quality of products and services for patient safety. Dr. Havern graduated from Duquesne University with a PharmD in 2009 and is currently pursuing a Master’s Degree in Precision and Personalized Medicine from the University of Florida. She served as the Coordinator for the Medication Management SIG for the 2020–2021 academic year and is looking forward to continuing to support APhA in additional roles. As a passionate member and advocate of the pharmacy community, Dr. Havern is committed to providing better patient-centered care across the community pharmacy setting and empowering her fellow pharmacists with the education and training necessary to provide more personalized medicine to our patients.

Statement of Candidacy

Patient care has rapidly transformed in this pandemic era and showed the world how quick and resilient our profession can be. However, the profession is poised to be impacted further by emerging science, technology, and especially policy. The Academy should be a leader in preparing the pharmacy field for these challenges and opportunities. We need to be ready, willing, and able to meet patient care needs where the patients are, or where they are not, in the case of telehealth; and we also need to be appropriately compensated for these services. Personalized medicine needs to be at the forefront of our minds, which should lead to community-based pharmacists having a larger role in direct patient care and clinical treatment decisions. I hope to utilize my current certification and advanced studies in pharmacogenomics to educate and empower pharmacists to leverage this knowledge and provide more effective patient-centered care. We must focus on continuing to publish effective resources to help members in their current pharmacy practices. Policies and laws affecting our profession are rapidly evolving. Our duty as an Academy is to keep our members abreast of the most recent policy changes and be a clearinghouse for information to the field and a source of “best practices” around those new policies. Lastly, we need to focus on recruiting and engaging our members. Our strength is in our numbers, and we should focus resources on engaging more members to join and stay involved in our organization. As a graduate of the LEAD360 program, I can vouch for the value these programs provide to my personal and professional development and highly encourage our members to take advantage of these opportunities.

Deanna Tran, PharmD, BCACP

Deanna Tran, PharmD, BCACP, is an Assistant Professor in Pharmacy Practice and Science and Co-Director of the Pharmacy Practice Laboratories at the University of Maryland School of Pharmacy. Dr. Tran earned her Doctor of Pharmacy degree from the University of Maryland and completed a PGY1 Community Pharmacy Residency at Virginia Commonwealth University School of Pharmacy. She is Board Certified in Ambulatory Care. As a clinical pharmacist in a family medicine practice, she provides medication therapy management under collaborative practice agreements. Dr. Tran is passionate about the mentorship of students and new practitioners. She serves as a residency preceptor for PGY1 Community Pharmacy Residency Program, APhA-ASP chapter advisor, and preceptor for both teaching and ambulatory care rotations. She has received the APhA-ASP Outstanding Chapter Advisor Award and the Mentor Award from the Maryland Pharmacists Association (MPhA). In addition, she has served on the APhA New Practitioner Advisory Council and founded MPhA’s New Practitioner Network. Dr. Tran is committed to advancing patient care services, serving as a practice transformation coach for Community Pharmacy Enhanced Services Network Maryland and a trainer for APhA’s Immunization and Medication Therapy Management Certificate Programs. Recently, she served as APPM Immunizing Pharmacists SIG Coordinator and has served on numerous APPM standing committees. Her current teaching and research interests include immunizations and the advancement of ambulatory/community care as well as pharmacy education especially in skills-based courses.

Statement of Candidacy

I believe the academy should position the profession of pharmacy for success through these three priorities: 1) Maintain our expanded scope of practice. COVID-19 emergency orders permit pharmacists to help with public health efforts including pediatric vaccinations and point-of-care testing. The Academy must lead initiatives in maintaining this scope of practice and pursuing reimbursement for these critical services. Through my experience in community and ambulatory care and as an APPM delegate in the APhA House of Delegates, I plan to use my voice, especially through social media, to promote the value of pharmacy. 2) Develop strategies to ensure the well-being of pharmacists, technicians, and student pharmacists. We are not immune to the mental and physical stresses of the pandemic. Developing strategies to address well-being is more important than ever, including establishing programs, support groups, and the means to further connect. Specifically, adapting to an increasingly virtual environment is critical. We must transform the Engage community and social media outreaches to develop new means to share our stories. I plan to leverage my experiences as a previous SIG leader and pharmacy educator in promoting well-being and working with new digital platforms. 3) Shape public health through action and dialogue. Diversity and inclusion are part of critical conversations taking place in the community, and pharmacy is a part of the public health fabric. We should support community-specific needs: decreasing stigma, promoting health literacy, and increasing access to medications and preventative health. Having worked with vulnerable communities, I can develop training and public health resources to transform the practice of pharmacy. As a SIG coordinator, I led the Academy’s first cross-collaboration initiatives between all SIGs, facilitating dialogue to meet the needs of our membership. With this experience, I will work with our SIGs to pool our members’ interests and identify key priorities.

APhA–APPM Executive Committee Member-at-large (2022–2024), Pair III
Trisha Chandler, PharmD, MS in Emergency Management*

LCDR Trisha Chandler, PharmD, is a United States Public Health Service Officer at Indian Health Service, where she is the pharmacy manager for satellite clinic pharmacies located on remote Native American reservations. LCDR Chandler has over a decade of practice experience in a variety of health care settings. She graduated from Midwestern University cum laude in 2005 and started her career managing a community pharmacy for 7 years, precepting student pharmacists, providing immunizations, and setting up community vaccination events. As a clinical pharmacist providing direct patient care to underserved populations, LCDR Chandler has received certifications and training in smoking cessation, cardiovascular risk reduction, and psychiatric medicine. She initiated MTM services for patients on remote reservations with limited access to care. She also initiated a mass flu vaccination program at one of the few remaining boarding schools for Native American/Alaskan Native students, housing on average 350 students annually. In 2018, she collaborated with APhA to develop a Toolkit for marketing medication therapy management to prescribers nationwide. LCDR Chandler is currently serving as the APhA Co-Chair for Care of Underserved Patients SIG education committee. She has deployed with the United States Public Health Service on several missions, providing direct patient care, emergency management of medications, and opioid rapid response training. *LCDR Chandler is currently working on her Master of Science in Emergency Management to incorporate and utilize pharmacists in public health, as one of the most accessible providers in the integrative health care team. She is native to Arizona and enjoys living an active lifestyle on her small hobby farm, riding her horse and spending time with friends and family.

Statement of Candidacy

I am honored to be nominated for the APhA–APPM Executive Committee. As a pharmacist with over 15 years' experience in a variety of pharmacy industries, I am devoted to supporting and expanding the role of pharmacists, as we truly are one of the most accessible health care providers available. I would like to assist APhA in reaching their goals through support and guidance, focusing on specific topic areas to include the following: 1) Growth and membership: It is difficult to engage and keep members engaged for any organization. I would like to assist in this process by utilizing network connections and capitalizing on the interests of our current and future members, while assisting to grow our professional organization and special interest groups. 2) Educational and innovative materials: Maintaining and staying up to date on current pharmacy related topics, guidelines, and educational materials are challenging for all pharmacists in their day-to-day work environment and personal time. It is important that APhA maintains up-to-date educational and innovative materials on a nationwide platform for pharmacists to access and be comfortable using. 3) Leadership development: Developing and embracing leadership does not follow a specific template or instructions. The Academy can assist to develop leadership skills for pharmacists by providing training, continuing education courses, and workshops. Providing the right tools and guidance, pharmacists can continue to become valuable assets and obtain leadership positions in our collaborative health care teams. I believe my previous experiences will assist to expand the roles of pharmacists and further develop these roles in the public health system.

Jessica Marx, PharmD, BCPS

Jessica Marx, PharmD, BCPS, completed her Bachelor of Science in Allied Health Sciences at the University of Connecticut, followed by her PharmD at MCPHS University in Manchester, NH. Dr. Marx works full-time at Portsmouth Regional Hospital as a clinical inpatient and emergency medicine pharmacist, in addition to part-time at CVS Health and Exeter Hospital. Passionate about teaching, Dr. Marx also serves as a preceptor to PGY1 pharmacy residents and student pharmacists at her primary practice site, Portsmouth Regional Hospital. Previously, Jessica served as an APhA–ASP chapter President, Ambassador at the APhA Institute in Salt Lake City, member of the APhA New Practitioner Network Communications Standing Committee, and 2 years on the APhA NPN New Practitioner Advisory Committee as Chair and Vice-Chair. Most recently, Dr. Marx serves on the APhA–APPM Communications Standing Committee. In her free time, Dr. Marx enjoys eating ice cream, crossword puzzles, traveling (specifically to Disney), and spending time with friends and family.

Statement of Candidacy

Working in multiple practice settings, I have witnessed firsthand the challenges pharmacy faces, and know we must first advocate for our profession. Specifically, in community practice, the current focus on dispensing requires a shift towards innovative pharmacy services designed to improve outcomes, not just bottom lines. This cannot be achieved without provider status legislation. APhA has long pursued passage of this legislation, but it requires increased involvement in order to become a reality. As a former APhA–ASP Chapter President and Chair of the New Practitioner Advisory Committee, I have had success in connecting with and building passion within the new generation of pharmacy practice leaders. This experience will serve to broaden the reach of APhA–APPM in our advocacy efforts. Second, we must focus on creating and demonstrating value for APhA–APPM members. The benefits of APhA overall often go unnoticed, and that effect is compounded when considering the specific Academies. In particular, I feel I can bring experience and skills necessary to demonstrate this value to the important demographic of new and future pharmacists. In direct collaboration with APhA–ASP and the New Practitioner Network, we can provide value to newer members while learning how to best appeal them as an Academy. Lastly, we must support our pharmacy technician colleagues by advocating for their expanding roles. Empowering pharmacy technicians can serve to improve patient access to services and increase the ability of pharmacists to provide thorough and innovative care. My experience as a pharmacy manager helped me understand how to approach these challenges and create novel, impactful solutions. I believe I can help APhA–APPM serve as a driver of the profession’s efforts to utilize all pharmacy staff to the best of their capabilities, and ultimately provide care to the patients whose lives can be transformed by the work we do.

APhA–APPM Special Interest Groups (SIGs) Candidates

APhA–APPM Care of Underserved Patients Special Interest Group Coordinator-elect (2021–2022)
Lisa Scholz, PharmD, MBA, FACHE

Lisa Scholz, PharmD, MBA, FACHE, pharmacy is her foundation. Being a 340B pharmacy steward drives her to demand what is right for patients in underserved communities. The opportunity to effect change in health care motivates her. Our communities inspire her to wake up every day with passion to exceed and drive results. EXPERIENCE: Her experiences in health care have driven her to be an inclusive, trusted thought leader. She is known nationally as a 340B evangelist with a career path that spans community pharmacy, nonprofit health systems, government, association management, and technology. When she is engaged, she learns and knows her subject matter and speaks with passion and conviction. With over 150 presentations, her style is convincing, engaging, factual, and articulate; not only with pharmacists, but with other professionals as well. RELATIONSHIPS: Her relationships and understanding of the market help her focus on developing collaborative teams that implement solutions and achieve goal-oriented outcomes. She is a key strategic partner in developing solutions to complex challenges. She has worked with countless leaders in pharmacy, health care, and other professional and trade associations. Additionally, her experience working both inside and outside of the federal government has helped her navigate strategy necessary to succeed. LEADERSHIP: Her leadership style has a signature approach that has attracted successful team members to create opportunities, solutions, and processes as a team. Her strengths are strong discipline and focus that leads to successful execution. Her persistence results in the timely deployment of engaging discussions with a unique balance that relates to people and motivates them to make changes.

Statement of Candidacy

The Care of Underserved Patients SIG has three priorities that will best support our success as pharmacists to lead and support those most in need: Engagement, Education, and Empowerment. E is for every pharmacist. Every pharmacist has encountered a patient who couldn't afford their medicine. Every pharmacist has helped a patient make a tough decision on affordability. Every pharmacist has impacted an underserved patient. But not every pharmacist has the engagement, education, or empowerment. Our SIG will prioritize engagement, education, and empowerment to support EVERY pharmacist to be an advocate for the underserved. ENGAGEMENT to continue to develop the diverse network of pharmacists, residents, and student pharmacists with interest in providing care to underserved patients. The answers are in the network. EDUCATION and learning about programs, services, and resources to support the underserved population are integral to pharmacists who are often asked for information on affordability or access to medications, programs, or medication services and being able to identify disparities at the point of care. Knowing where to find those answers is key. EMPOWERMENT of pharmacists in all settings to support caring for diverse underserved patients and be their voice. Be the voice your patient deserves. I have been part of the original CUP SIG as part of the leadership team and advocacy chair for the last 2 years. I've grown to understand the APhA volunteer structure, processes, and leadership. More importantly, I've learned that pharmacists from all practice settings are impacted and want to help connect patients in need. My experience in serving as a leader in the safety net has prepared me to lead our pharmacy profession to better understand resources available to our profession and patients. More importantly, our profession needs to have a place to engage, be educated, and be empowered. Thank you for the opportunity to serve my profession.

Anna Staudt, PharmD

Anna Staudt, PharmD, is a Clinical Pharmacist at a multicenter Federally Qualified Health Center (FQHC) in Columbus, OH. She received her PharmD from Cedarville University. Upon graduation, she completed a Community Pharmacy Practice Fellowship through Cedarville University School of Pharmacy, where she served in two roles, as a Clinical Pharmacist and an Instructor of Pharmacy Practice. Her fellowship clinical practice site was an FQHC in downtown Columbus, where the majority of the patient population was homeless. As the first Clinical Pharmacist at this FQHC, she developed their clinical pharmacy services to offer chronic disease state management and served in a dispensing role in the clinic's free pharmacy, where select medications were dispensed to uninsured or underinsured patients. After the fellowship, she transitioned into a Clinical Pharmacist position at a different FQHC after the organization had a period of time without clinical pharmacy services. She redeveloped these services and now offers chronic disease state management focusing on diabetes, hypertension, dyslipidemia, asthma, COPD, smoking cessation, and HIV PrEP. She also assists with 340B program and quality improvement initiatives and serves as a preceptor to pharmacy students. Most recently, she has served in the APhA–APPM Care of Underserved Patients SIG as an ENGAGE Moderator (2018–2020), Communications Committee Co-Chair (2019–2020), and Communications Committee Chair (2020–2021). Her clinical interests include diabetes, hypertension, and HIV. Professionally, Dr. Staudt is involved in various organizations, including APhA, the Ohio Pharmacists Association, and the American College of Clinical Pharmacy.

Statement of Candidacy

The APhA–APPM Care of Underserved Patients SIG provides a great way for pharmacists from various backgrounds to connect through their passion for serving the underserved and learn about ways we can advocate for our patients. I believe our SIG should continue to grow by focusing on three priorities: 1) Promote engagement and encourage members to communicate/collaborate. As the ENGAGE moderator for the past 2 years, I helped track member involvement in the SIG and worked on the communications subcommittee to identify discussion topics to promote conversation. I want to continue to identify hot topics and display this information in a comfortable, fun, and engaging way that sparks interest in interacting with others and in sharing experiences, such as quizzes, journal clubs, and interactive platforms, as well as providing a way to network. 2) Understand the needs of SIG members and develop beneficial educational activities/resources. I believe we need to better identify the needs of members to develop more educational opportunities. Many people are members of this SIG to share and gain resources that will assist in caring for patients and developing clinical practice. However, these resources are currently limited. I have worked with the education and communications committees over the past few years to assess member interest and organize resources in the SIG library and notify members of the available resources. 3) Advocate for the underserved population and organizations that serve the underserved. Not everyone understands the circumstances many underserved patients face, and I believe it is our duty to educate and advocate for our patients. I want to help provide resources to ENGAGE that others can use to better understand the population, educate others, and advocate. I have informed students and guided them for the past 3 years to best serve the underserved as a preceptor.

APhA–APPM Compounding Special Interest Group Coordinator-elect (2021–2022)
Natalie Young, PharmD, FACVP

Natalie Young, PharmD, FACVP, is the Director of Realo Veterinary Pharmacy, North Carolina’s only veterinary-exclusive pharmacy. She is the President-Elect of the American College of Veterinary Pharmacists (ACVP) and the President of the North Carolina Veterinary Medical Association’s Industry Council. Natalie is a graduate of the North Carolina School of Science and Mathematics and UNC Chapel Hill (Bachelor's degree in Chemistry). In 2016, she received her Doctorate from the UNC Eshelman School of Pharmacy. Over the course of her career, Natalie has had the privilege of being mentored by experts in both compounding and veterinary pharmacology, including serving as a Visiting Scholar at NC State University’s College of Veterinary Medicine under Gigi Davidson. Natalie’s other activities include staffing as a Clinical Community Veterinary Pharmacist to local veterinary clinics, leading numerous veterinary research studies and serving as a specialty preceptor to UNC Chapel Hill graduate students.

Statement of Candidacy

As the SIG Coordinator-elect for Compounding, the 2021 year will have a heavy focus on changes within our industry. Compounding will be one of the most active and important special interests, requiring APhA to have strong, diligent coordinators on this team. Three key areas of focus will be communication with our membership around changes to USP (namely <795>, <797> and <800>), APhA representation to USP as a stakeholder and participant with their leadership as they finalize these versions, and crafting updated continuing education content for APhA to offer to their membership around the changing world of compounding. My educational background in compounding, experience building, and directing a compounding pharmacy prepared for the changes coming, and close relationships with key personnel on the USP expert committees provide a unique opportunity and position to fundamentally assist APhA over the next several years.

APhA–APPM Diabetes Management Special Interest Group Coordinator-elect (2021–2022)
Aimee Dawson, PharmD

Aimee Dawson, PharmD, is an Assistant Professor in the department of Pharmacy Practice at MCPHS University–Worcester Campus. She has served as a co-chair for the Professional and Student Affairs committee within the APhA–APPM Diabetes SIG since 2017. Dr. Dawson graduated from the University of Connecticut in 2012 and completed a PGY1 community residency at Holyoke Health Center, in Holyoke, MA. Holyoke Health Center continues to serve as her clinical practice site where she precepts APPE students and PGY1 residents. At her practice site, Dr. Dawson is involved in several clinical pharmacy services, including medication therapy management, transitions of care, and most recently, collaborative drug therapy management for diabetes. Dr. Dawson also serves as a preceptor for the medical information/medical affairs fellowship program with MCPHS University and Sunovion.

Statement of Candidacy

The three top priorities include: 1) Continuing to serve as a resource for practicing pharmacists in the field of diabetes. 2) Continue to encourage members to be engaged. 3) Continue to develop innovative ideas and programming. Throughout my role as co-chair for the Professional and Student Affairs SIG, I have been able to see first-hand the benefits the SIG provides for its members and leaders. I see APhA and specifically the Diabetes Management SIG as being the go-to resource for pharmacists attempting to implement clinical pharmacy services for patients with diabetes. Engaged membership is what drives the discussion boards and the sharing of ideas and unique practices. These three priorities added together will allow pharmacists across the country to excel. When pharmacists excel, it allows our profession to advance. I am a huge advocate for our profession and appreciate all of the work APhA does on behalf of pharmacists when it comes to advocacy and provider status. I see the SIG as an extension of this. Preparing and supporting the "boots on the ground" to be practicing at the top of their license so that we can continue to advance and improve patient health. Throughout my role as an Assistant Professor, I have had experience chairing several committees. I think a good chair is organized, delegates tasks, and sees value in the work the committee is doing. I feel that I fit all of those categories.

Nicholas Lehman, PharmD, BCACP

Nicholas Lehman, PharmD, BCACP, is an Associate Professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences. He also serves as a clinical pharmacist at the UnityPoint West Des Moines Internal Medicine and Family Medicine Clinics and as an Adjunct Clinical Professor at the University of Iowa Carver College of Medicine. Dr. Lehman received his Doctorate of Pharmacy from The University of Iowa in 2003. He completed a Primary Care Pharmacy Practice Residency at the Iowa City VA Medical Center in 2004, and joined the faculty at Drake in 2010. Dr. Lehman obtained Board Certification in Ambulatory Care Pharmacy in 2012, and is an active member of APhA and the Iowa Pharmacy Association. Dr. Lehman’s current practice and research interests include anticoagulation therapy, diabetes, transitions of care, and immunizations.

Statement of Candidacy

The practice of pharmacy and the health care system as a whole are constantly changing. I believe the Diabetes Management SIG can be an excellent resource for practitioners and students to continue to gain valuable information to better care for patients with diabetes. Through my service as the Chair of the Diabetes SIG Education Committee, I have been able to help provide resources, both through formal continuing education programs and informally through the ENGAGE platform, to contribute to that lifelong learning process. Another goal of the SIG should be to continue to engage the current members of the SIG, as well as to seek new members who have not previously been involved. I feel that one of the best ways to accomplish this goal is by collaborating with other SIGs, as well as our new members and student pharmacists. By broadening the SIG membership, there will hopefully be an increase in the diversity of thoughts and opinions that would contribute to learning and patient care. I believe it's important to continue providing a variety of educational offerings and seek new, innovative ways to engage the members. Ultimately, the goal of the SIG should be to provide members with the tools to better care for their patients. One of these tools is the ability of pharmacists to be recognized as providers and reimbursed for the care provided to patients. The SIG should continue to be a space for pharmacists to ask questions and provide guidance regarding successes and areas of improvement. As a member of the APhA–APPM Policy Standing Committee as well as a delegate to the APhA House of Delegates, I have been fortunate to see the hard work being put in to make these changes sustainable and hope to continue to involve the Diabetes Management SIG in the legislative process.

APhA–APPM Immunizing Pharmacists Special Interest Group Coordinator-elect (2021–2022)
Laura Knockel, PharmD, BCACP

Laura E. Knockel, PharmD, BCACP, is a Clinical Assistant Professor at the University of Iowa College of Pharmacy and an ambulatory care clinical pharmacist at the University of Iowa Hospitals and Clinics. Dr. Knockel received her PharmD from the University of Iowa in 2005 and completed a PGY1 Pharmacy Practice Residency with an Emphasis in Community Care with the University of Iowa College of Pharmacy and Hy-Vee Pharmacy in Cedar Rapids, IA. She teaches in the pharmacy practice skills laboratory, focusing on community pharmacy skills, including coordinating immunization and self-care topics. Dr. Knockel serves as the faculty advisor for the Beta Epsilon chapter of Phi Lambda Sigma. She was chosen as Teacher of the Year for the P1 class in 2018. Prior to joining the faculty at the University of Iowa in 2015, she worked as a pharmacist at Hy-Vee Pharmacy in Iowa City, IA, for 10 years, where she helped implement an AADE-accredited diabetes self-management education program. Her areas of interest include immunizations, self-care, the scholarship of teaching and learning, innovative teaching methods, and advancing community pharmacy practice. Dr. Knockel was selected for the 2020–2021 National Association of Chain Drug Stores (NACDS) Foundation Faculty Scholars program, an 18-month program focusing on community-based research. As a member of the Immunizing Pharmacists SIG, she has served on the Education Committee and is currently co-chair of the Communications Committee.

Statement of Candidacy

I believe the top three priorities of the Immunizing Pharmacists SIG should be increasing members' awareness of the vaccine development process, increasing ways for members to become more involved in pediatric immunizations, and increasing new practitioner involvement in the SIG. As the most accessible health care providers, pharmacists can help stop the spread of misinformation by educating patients on how vaccines are developed and the measures being taken to ensure vaccine safety and efficacy. My experience on the SIG's Communication Committee has shown me how to assist with the organization and dissemination of such information through the ENGAGE platform. Providing all pharmacists with refreshers on the different phases of vaccine development and information on new vaccine approvals would be a natural fit for the SIG. The U.S. Department of Health and Human Services authorizing pharmacists, interns, and technicians under the PREP Act to administer childhood vaccinations during the pandemic provides us with the opportunity to become more involved in pediatric immunizations. The SIG can provide the support needed through educational materials and having members share their experiences for others to feel comfortable with vaccinating pediatric patients. As new practitioners make the change from student to pharmacist, encouraging their involvement in the SIG may help their ease their transition, as well as inspire long-time pharmacists with fresh ideas and new techniques currently being taught in pharmacy school. I would like to see one to two new practitioners on each SIG Committee to promote involvement and sharing of diverse viewpoints.

Jennifer Wilson, PharmD

Jennifer (Jenn) Wilson, PharmD, is an Associate Professor of Pharmacy and Director of Introductory Pharmacy Practice Experiences (IPPE) at Wingate University School of Pharmacy. She earned her PharmD from Ohio Northern University. Upon graduation, she completed a postgraduate community pharmacy residency with Kerr Drug and UNC Eshelman School of Pharmacy in Raleigh, NC. Following residency, Dr. Wilson completed a 1-year academic fellowship at UNC in the pharmaceutical care lab. She joined the Wingate faculty in 2012. She is Board Certified in Ambulatory Care. She was most recently a clinical pharmacist at the Community Health Services of Union County free medical clinic, until transitioning into the role of IPPE Director in May 2020. She coordinates and teaches in several courses, including self-care pharmacotherapy, therapeutic lifestyle changes, immunizations, and medication therapy management. She worked part-time as a community pharmacist for 6 years. Dr. Wilson is active in APhA, the American Association of Colleges of Pharmacy, and the North Carolina Association of Pharmacists. Within APhA, she first became involved as a new practitioner, serving on several committees, including the New Practitioner Advisory Committee. In more recent years, she has been most involved with both the Immunizing Pharmacists SIG and Diabetes Management SIG. She currently serves as co-chair for the Immunizing Pharmacists SIG Travel Health Guide Task Force. She is also a trainer for the APhA Immunization Certificate Program, as well as the Medication Therapy Management Certificate Program.

Statement of Candidacy

I want to express my sincere interest in the position of Coordinator-elect for the Immunizing Pharmacists SIG. I have enjoyed serving on SIG committees over the years, including most recently as co-chair for the Travel Health Guide Task Force. I would bring my passion for immunizations and professional involvement to this position. The three key priorities for the Immunizing Pharmacists SIG include: 1) Keeping members up to date regarding current recommendations. Immunization information continually changes. As pharmacists play an integral role, it is essential we stay current with information. APhA provides many tools to enable this, including the Immunization Reference Guide and Travel Health Guide. These require annual updating, which should continue as a SIG priority. Having served on both task forces, I have a solid understanding of these two documents. Webinars provide an additional avenue for education. Having served on various programming and education committees, including the SIG's, I can provide support to this committee. 2) Continuing to emphasize the importance of advocacy, particularly related to immunizations. Pharmacist immunizing authority continues to expand, and there is an increasing need for pharmacist involvement in vaccinating, as evidenced during the pandemic. We must continue to advocate for pharmacists' authority related to immunizations. 3) Encouraging networking, communications, and connections among SIG members. The ENGAGE platform provides one main avenue to help connect members. The SIG has also developed a database to compile information to better connect immunizing pharmacists, and promoting should continue as a priority. This also provides a means to achieving the first two priorities.

APhA–APPM Medical Home/ACO Special Interest Group Coordinator-elect (2021–2022)
Darren Mensch, PharmD, BCPS, BCACP

Darren Mensch, PharmD, BCPS, BCACP, graduated from Wilkes University in 2015 with a PharmD and a BA in Spanish. Following graduation, he pursued a PGY1 Pharmacy Residency at Penn State Health St. Joseph in Reading, PA, and continued as staff pharmacist and ambulatory care preceptor for 3 years. He then went to join Jefferson Medical Group in April 2018 to help start the organization's population health pharmacy team as part of the Comprehensive Primary Care Plus program. Under the direction of the population health team and physician network at Jefferson Health, the pharmacy team plays an integral role in performing comprehensive medication management and implementing medication processes or programs to improve the patient and clinician experience while improving outcomes and lowering costs. Among four pharmacists throughout Jefferson Medical Group, there are about 60 primary care offices and over 300,000 patient lives, so much focus has been placed on population health management to best identify patients. In addition, Dr. Mensch and his team were recently featured in the Medical Home/ACO SIG's "Successful Integration of Pharmacists in Accountable Care Organizations and Medical Home Models: Case Studies" resource. Dr. Mensch now serves on the Medical Home/ACO SIG's Education and Resources Committee. Outside of APhA, Dr. Mensch is also an active member of the Pennsylvania Pharmacists Association, serving on the Health System Advisory Board and Primary Care Consortium's Membership Working Group. Darren is an avid golfer and loves to cook.

Statement of Candidacy

1) Improved advocacy outside of the pharmacy profession: Although there are some ACO/PCMH programs with pharmacists on board, I feel our profession needs to gain more traction and support from outside entities because a lot of people (patients included) did not realize how helpful having a pharmacist in an office is until our team started. In my opinion, we do a great job advocating for our profession within our own ranks, but we need more support from medical professionals, leadership, and even nonmedical fields. Recently, I have made it a point to present at outside organizations, such as the Collaborative Family Healthcare Association's national conference, the Institute for Healthcare Improvement National Forum, and various local organizations to help advocate for pharmacist integration. 2) Education on value-based care and population health: I feel ACOs and PCMHs are poised to continue to take on a more robust role as health care shifts to a more value-based model. With my role as a population health pharmacist and embedded clinical pharmacist covering 15 primary care offices, our team has found a way to integrate ourselves while providing a high level of care for patients. In addition, I enjoy listening to podcasts around value-based care and believe pharmacists need to better position themselves to be leaders in those conversations especially given the skyrocketing pharmaceutical costs. 3) Improving communication between community pharmacy and provider offices: In working at multiple provider offices over the past few years, I have noted a major disconnect between what role physicians think pharmacists play and vice versa. I think the main reason for this is poor communication. If communication improved at the PCMH and/or ACO level by implementing better strategies (with technology, etc.), both sides would know each other's role leading to efficient workflows, thus improving the patient/clinician experience.

APhA–APPM Medication Management Special Interest Group Coordinator-elect (2021–2022)
Tosin David, PharmD, BC-ADM

Tosin David, PharmD, BC-ADM, is an Assistant Professor of Pharmacy Practice at the University of Maryland Eastern Shore School of Pharmacy and Health Professions (UMES-SOPHP), where she serves as the Pharmacy Skills Coordinator. Dr. David has a practice site at a local independent pharmacy, where she completed a Community-based Pharmacy Residency program in 2017. Dr. David currently serves as the co-advisor for the UMES-SOPHP chapter of the APhA Academy of Student Pharmacists (APhA–ASP). Her leadership involvement within APhA–APPM includes serving as the Clinical Committee chair, where she oversees the Clinical Guidelines webpage. Additionally, Dr. David has created new projects focused on the pharmacist’s role in improving quality measures. Dr. David has a passion for improving the health of the community around her. She is committed to being a patient advocate throughout the continuum of care. As a community pharmacist, she strives to improve the quality and economic burden of medical care by implementing innovative practices that focus on rural health and diabetes management.

Statement of Candidacy

1) To expand Medication Therapy Management services to Medication Management Services. Pharmacy practice continues to evolve, and now more than ever, it is time to implement various medication management services. These types of services require pharmacists to document services through pharmacy ecare plans and to showcase clinical outcomes. 2) To provide practical and impactful resources for pharmacists in a wide variety of settings. Pharmacists can find tools to develop their medication management services from the four current committees within the Medication Management SIG. As a practicing pharmacist, I always look to find useful tools from APhA that I can use in my practice. My goal is to continue updating current resources found within the Medication Management SIG and work with the SIG’s members to create new impactful resources for practicing pharmacists. 3) To inspire collaboration and innovation. The Medication Management SIG serves as a great platform to develop programs as the profession faces many new opportunities to provide patient care. Despite how the profession evolves, medication management will always be the core of pharmacy practice. My goal is that the Medication Management SIG will be a source for pharmacists to share resources, initiatives, and information that impact medication management. By utilizing the ENGAGE platform, pharmacists will have the ability to share experiences and resources and probe thoughtful questions to spark collaboration and innovation.

Taylor Mathis, PharmD, MS, BCACP

Taylor Elise Mathis, PharmD, MS, BCACP, graduated from the University of Mississippi School of Pharmacy in 2016 and completed a PGY1/PGY2 Community Pharmacy Administration Residency through Kroger Health and The University of Cincinnati in 2018, during which she obtained a Master of Science in Pharmaceutical Sciences degree with an Emphasis in Health Outcomes from the University of Cincinnati James L. Winkle College of Pharmacy. She is now thoroughly enjoying her third year as an Assistant Professor of Pharmacy Practice at Union University College of Pharmacy in Jackson, TN, where she practices as an ambulatory care pharmacist within a local family medicine office. Dr. Mathis has always been passionate about teaching and helping others, so her current position allows her to pursue those passions and find great joy and fulfillment in her work. She firmly believes that pharmacists are a key component of the health care team and enjoys working collaboratively with other health professionals to provide excellent patient care to improve health outcomes. She is currently serving her new practitioner colleagues as Chair of APhA's New Practitioner Network Education Standing Committee. She is also an active member of the Medication Management Special Interest Group's Clinical Committee and the Diabetes Management Special Interest Group. APhA has a played a significant role in Dr. Mathis's professional development thus far in her career, and she is excited for the possibility of serving the profession in the role of Medication Management SIG Coordinator-elect, if elected.

Statement of Candidacy

The purpose of APhA's Medication Management Special Interest Group (MM SIG) is to "serve as a conduit for APhA to address the needs of practicing pharmacists in order to continuously and actively shape the provision of pharmacist-led MTM services into financially viable models of practice that improve patient outcomes." Over the next few years as our scope of practice continues to evolve, I feel that a few of the MM SIG's top priorities will be to: 1) provide timely, up-to-date resources for practicing pharmacists, 2) equip practicing pharmacists with the confidence to use their clinical knowledge to improve patient outcomes, and (3) create opportunities for pharmacists to share innovative practice models with one another. My background in community pharmacy residency, academia, and ambulatory care, as well as my involvement in the MM SIG, the Diabetes Management SIG, and the New Practitioner Network, have given me experience in developing timely resources for peers, writing patient cases to support clinical practice, and engaging in both in-person and virtual networking events. I would love the opportunity to work with the MM SIG committees and members to continue many of the current activities but also to create new opportunities for pharmacists in all settings to collaborate and move the profession forward through innovative, successful practice models. In the era of COVID-19, collaboration can prove to be difficult; but there are a variety of avenues available for pharmacists to work together and learn from one another via the ENGAGE community, virtual networking sessions, or social media. I hope to use my experience to support the SIG in pursuing its purpose and providing practicing pharmacists with an outstanding community to learn, grow, and thrive professionally in the years to come.

APhA–APPM Nuclear Pharmacy Practice Special Interest Group Coordinator-elect (2021–2022)
David Barnes, RPh, BCNP

David Barnes, RPh, BCNP, has been practicing nuclear pharmacy for the last 30 years after a brief time working in hospital, home health, and community pharmacy. He has been active in APhA, attending all Annual Meetings since 1999, and served on the Executive Committee of APhA–APPM as Member-at-large in recent years. He is currently active on both the Awards and Regulatory Committees of the Nuclear Pharmacy Practice SIG and serves as internship coordinator for RLS USA, Inc. In addition to responsibility for all aspects of 10 nuclear pharmacy site operations, he has corporate responsibility for some aspects of national contracts, customer relations, and setting pharmacy SOPs and education programs within RLS. In the past, Mr. Barnes has had responsibility for various areas of nuclear pharmacy compliance within the company and adoption of USP in 31 network pharmacies. He is currently involved in an expansion program and business development for RLS.

Statement of Candidacy

My top three priorities are: 1) Regulatory Compliance. With USP becoming official near the end of 2020, it is crucial to nuclear pharmacies to maintain compliance and educate our lawmakers and regulatory bodies on the nuances of how compliance impacts our practice. This has already started in 2020 with the regulatory committee beginning work on a checklist for nuclear pharmacies; as a member of the USP expert panel, a primary focus should be to keep attention on this subject going forward. 2) Student/New Practitioner Involvement. Our SIG members and many of us who have participated for years are getting closer to the end of our careers; though our SIG is not as large as some, we have excellent consistency and high passion for nuclear pharmacy. It will be a goal for our entire SIG to get students and new practitioners involved to pass the baton. 3) Outreach. We have been established for so long and have maintained strong leadership internally; we need to use our skills to assist other SIGs as much as possible with their growth.

APhA–APPM Pain, Palliative Care, and Addiction Special Interest Group Coordinator-elect (2021–2022)
Emily E. Leppien, PharmD, BCPS

Emily E. Leppien, PharmD, BCPS, is originally from Buffalo, NY. She received her PharmD from Albany College of Pharmacy and Health Sciences. Following graduation, she completed 2 years of postgraduate residency training at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and Buffalo Psychiatric Center, specializing in neurologic and psychiatric pharmacy. Dr. Leppien joined Binghamton University School of Pharmacy and Pharmaceutical Sciences in August 2018 as a Clinical Assistant Professor within the Department of Pharmacy Practice. She also serves as a Clinical Pharmacy Specialist at Lourdes Center for Pain and Wellness, where she provides pain management and behavioral health services as part of an interdisciplinary team. Her current research projects include 1) opioid and nonopioid pharmacotherapy, 2) complementary, alternative, and integrative medicine, 3) nonopioid alternatives for pain management (i.e., medical cannabis and low-dose naltrexone), 4) integration of behavioral health and OUD/SUD treatment within pain management services, and 5) interprofessional education. She is passionate about destigmatizing neuropsychiatric illnesses, including chronic pain, to provide effective and compassionate patient care. Dr. Leppien is actively involved in APhA. She currently serves as a Co-Chair of the APhA–APPM PPCA SIG Education Committee, and is a member of the APhA–APPM Education Standing Committee. Dr. Leppien also serves as a faculty co-advisor for APhA–ASP at Binghamton University School of Pharmacy and Pharmaceutical Sciences.

Statement of Candidacy

As opioids continue to be used as a mainstay of treatment for pain management, the number of individuals who misuse, abuse, or become dependent on such therapy continues to increase in prevalence over time. According to statistics provided by the Addiction Center, approximately 20%–30% of patients who take prescription opioids misuse them. Of that narrowed population, approximately 10% develop opioid use disorder (OUD). A top priority of the Pain, Palliative Care, and Addiction (PPCA) SIG should be to educate on alternative pain management strategies, including nonpharmacotherapy interventions. These educational efforts will optimize member learning and the care they provide to patients, adding value to their APhA membership experience. Currently, I serve as a coinvestigator and research mentor on research projects evaluating the efficacy of alternative pain management strategies, including ketamine, low-dose naltrexone, dronabinol, and medical cannabis. I am also actively involved in a research project evaluating barriers to the use of nonpharmacologic interventions. Another priority of the PPCA SIG should be to complete a needs assessment, encouraging feedback from current members, to ensure education and research resources are highly valuable and applicable to improving best practices. SIG leaders must continuously interact with members via the Engage platform and actively update the Opioid Resource Center to ensure dissemination of new and existing pain management resources. In addition to these efforts, significant attention should be placed on creating networking and professional relationship-building opportunities for students and pharmacists—ideally, an event where students interested in pain management, substance use disorder treatment, or palliative care can network with pharmacists currently working within those specialties. As Operation Substance Use Disorders becomes more prominent among APhA–ASP chapters, these networking events will improve student outreach programs to improve educational efforts regarding prescription medication safety.

Larry Selkow, RPh, BSPharm

Larry Selkow, RPh, BSPharm, has been a community pharmacist for almost 40 years. He is a staff pharmacist at Albertsons in Palm Desert, CA. He has a BS Pharmacy from Arnold and Marie Schwartz College of Pharmacy, Brooklyn, NY in 1982 and a BS Biology from Pennsylvania State University, 1979. He has been a member of APhA for almost 30 years. Mr. Selkow is very involved with many aspects of APhA, being a member of various Special Interest Groups and Committees. He is currently Communications Chair of the PPCA SIG and Public Health SIG. Mr. Selkow is also involved with APhA House of Delegates (HOD), serving as a delegate for many years and also serving on various committees within the HOD. On a local level, Mr. Selkow is President of his local chapter of the California Pharmacists Association. Serving as Communications Chair of the PPCA SIG, Mr. Selkow would like to be considered for SIG Coordinator. He is interested in Pain and Addiction Medicine, and would like to work with SIG members and students in this area. He feels his experience as communications chair and his SIG activities would make him a perfect fit as SIG Coordinator. Mr. Selkow is eager to work with the leadership of APhA to make the PPCA SIG better in all aspects. Promoting the activities of the PPCA SIG and working with others would be a top priority.

Statement of Candidacy

I have been a member of APhA for almost 30 years. I have been active with APhA in many activities. It would be an honor to be considered for SIG Coordinator of PPCA. The top three Priorities of the SIG: 1) Promote the SIG to APhA members, including student pharmacists, since the SIG is new and relatively small compared to other SIGs. 2) Bring more attention to addiction and pain medicine to members of APhA. 3) Work with other organizations in the area of addiction and pain medicine and form a liaison with APhA. Serving as Communications Chair of both the PPCA SIG and Public Health SIG, I feel my experiences would benefit me greatly as SIG Coordinator. Serving on various committees within APhA and forming relationships with those involved will help me serve this SIG in a better capacity.

APhA–APPM Preceptor Special Interest Group Coordinator-elect (2021–2022)
Ha Phan, PharmD, CDCES, BCACP

Ha Phan, PharmD, CDCES, BCACP, is an alumna of the University of Maryland School of Pharmacy. She completed her PGY1 Community-based Pharmacy Residency at the Johns Hopkins Home Care Group and then went on to complete her PGY2 Ambulatory Care Pharmacy Residency at the University of Mississippi. She is currently a Clinical Assistant Professor at the University of Mississippi, where she practices within ambulatory care at the Grant's Ferry Clinic in Flowood, MS, within Internal Medicine/Pediatrics and at the Children's Specialty Clinic within Pediatric Endocrinology, where she is launching an outpatient transitions of care program. She serves as the Community Pharmacy Interest Group co-advisor for Ole Miss and the Mississippi College of Clinical Pharmacy treasurer and secretary. She previously served as the New Practitioner Mentor to the University of Maryland APhA–ASP chapter and has spent the last year as the APhA–APPM Preceptor SIG communications committee chair and co-chair. She has had the pleasure to serve as a preceptor to the P2s, P3s, and P4s over the last few years, whether that be virtually or in person.

Statement of Candidacy

Something that I learned very early as a student pharmacist is the power of paying it forward. There is always someone you can lend a hand to, no matter your stage in your career, whether that be a student pharmacist helping a prepharmacy student or a seasoned practitioner aiding a new practitioner. This is something that I will always make time for: mentorship. I would not be where I am today if it was not for the time that others have invested in me. Which leads me to the importance of the Preceptor SIG, an area where we have these new practitioners, seasoned practitioners of all practice backgrounds, and many opportunities for mentorship. The Preceptor SIG is the only SIG that is made up of only pharmacists and serves as a safe space to gain resources, to elevate ourselves as preceptors, and to align with the needs of our membership. My three priorities for the Preceptor SIG are the following: 1) Increase our involvement in our SIG by 1%–2%, as many of us are preceptors, so we need to understand our needs to be able to meet them. 2) Hold one webinar or educational CE. 3) Provide one tool kit for preceptors that is applicable to all settings. These priorities will only be carried out if collaboration and communication are aligned between our membership and leadership. I propose that I will be able to forge and fulfill these priorities.

APhA–APPM Transitions of Care Special Interest Group Coordinator-elect (2021–2022)
Roxane Took, PharmD, BCACP

Roxane Took, PharmD, BCACP, is an Assistant Professor of Pharmacy Practice at St. Louis College of Pharmacy (STLCOP) at University of Health Sciences and Pharmacy. Her practice site is an independent pharmacy in St. Louis. As a clinical pharmacist, she completes medication therapy management (MTM) services for a little over 1,000 patients. The pharmacy also services a local physician's office through a clinical services agreement to provide annual wellness visits, chronic care management, and remote physiologic management. The pharmacy has recently partnered with a local health care system to provide TOC services through shared electronic health records. Prior to her current practice site, Dr. Took was a shared ambulatory care pharmacist at a local grocery store chain. She provided MTM services, delivered education through the diabetes care center, completed point-of-care testing, and assisted in postdischarge education and medication reconciliation through the pharmacy's pilot TOC program. Prior to her academic appointment at STLCOP, Dr. Took was a clinical pharmacist at a regional grocery store chain in Kansas City, MO. Dr. Took provided MTM for Medicare and Medicaid patients and grocery store employees as part of an employee health program. In this role as a clinical pharmacist, Dr. Took expanded the health program by implementing and managing a TOC program. Dr. Took was awarded a grant for the pilot program and results have been published and presented. Dr. Took is an active member of APhA, serving in various roles throughout the TOC SIG for the past 3 years as a co-chair for both the Practice Committee and Communication Committee (current).

Statement of Candidacy

If chosen as the TOC SIG Coordinator-elect, I would like to focus on the following areas: 1) Communication. As the current co-chair of the TOC SIG Communications Committee, I believe communication is key to our SIG’s success. We need to continue to openly communicate with our members regarding any issues and opportunities for involvement and to solicit input from our members. I would like to personally share any updates and information using the ENGAGE platform and continue to work with our communications committee to disseminate other important messages to our members.
2) Education. TOC has evolved dramatically since the early 2000s, when care transitions were primarily handled by nurses. Now pharmacists of all types are involved in TOC. I believe it's important for our TOC SIG to poll our members to identify areas of focus for our webinars and projects so we can meet our member needs.
3) Member Engagement and Retention. I have been an active member in the TOC SIG since 2017 and would love to see more of our members involved! I believe our SIG can improve in actively engaging our members. I would like to do this by having a quarterly Zoom call in which pharmacists can meet and socialize. These meetings can help connect members with pharmacists who work in similar environments or in the same region of the United States. I would love to use technology to connect TOC members throughout the country in research, scholarship, and socially. We have so many amazing members in our SIG who could serve as a mentor for our pharmacists new to transitions of care. I also believe that we have many seasoned pharmacists who could serve in a leadership role.

Election Process

Slating and introduction of candidates

Candidates for the Board of Trustees are slated by the APhA Committee on Nominations in early December and are introduced to Annual Meeting attendees at the First Session of the APhA House of Delegates. Annual Meeting attendees also have the opportunity to interact with these candidates at caucus events and "Meet the Candidates" sessions.

The APhA–APPM Committee on Nominations is composed of the APhA–APPM President, who serves as the chair of the committee, and the four Immediate Past Presidents of the academy. During years when there is a President-elect of the academy, the President-elect will serve as an ex-officio member of the committee. The APhA–APRS Committee on Nominations is composed of the APhA–APRS President, who serves as chair of the committee, and the three APhA–APRS Section Chairs. The election slates for these two Academies are finalized in December. Annual Meeting attendees have the opportunity to interact with APhA–APPM and APhA–APRS candidates at two "Meet the Candidates" sessions.

All individuals interested in applying to serve on the APhA Board of Trustees are required to review the APhA Conflict of Interest Statement and submit a corresponding Disclosure and Confidentiality Statement to APhA’s Legal Counsel.

Other APhA elections

The leadership of the APhA Academy of Student Pharmacists (APhA–ASP)—President-elect, Speaker of the House, and Members-at-Large—are elected at the final session of the APhA–ASP House of Delegates, held during the APhA Annual Meeting.

The Speaker-elect of the APhA House of Delegates is elected every even year by the APhA House of Delegates. The Speaker-elect serves until the end of the Annual Meeting following his/her election, at which time he/she is installed as Speaker and serves for two additional years.

*With the exception of those members appointed to serve in the APhA House of Delegates, student pharmacists are not eligible to vote in the APhA Election. Per election guidelines, the list of eligible voters is finalized 30 days prior to the opening of the official voting period. Individuals who join APhA within 30 days of the opening of the official voting period are not eligible to vote in the current election.